Rachael J. Keefe
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Rachael J. Keefe has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Christopher Spencer Greeley
Division of Public Health Pediatrics, Baylor College of Medicine and Texas Children's Hospital, 6701 Fannin St., Suite 1720, Houston, TX, 77030, USA
3 shared publications - Angela D. L. DrPH Cummings
Division of Public Health Pediatrics, Department of Pediatrics, Baylor College of Medicine, 1919 S Braeswood Blvd MB4210, Houston, Texas, 77030, USA
2 shared publications - Bethanie S. Van Horne
Baylor College of Medicine
2 shared publications Angela D. L. Cummings
Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA
1 shared publicationAshley E. Smith
Department of Psychiatry, Baylor College of Medicine, Houston, Texas, USA
1 shared publicationBethanie S. Van Horne
Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA
1 shared publication
Latest Publications
- 8 July 2026
- Published by Elsevier in Academic Pediatrics
- Vol. 26 (7) , 103390
The Glance Between Them
- 27 June 2024
- Published by American Academy of Pediatrics (AAP) in Pediatrics
- Vol. 154 (1)
State Implementation of Congregate Care Reforms for Children in Foster Care
OBJECTIVES: The Family First Prevention Services Act (FFPSA) allows states to use federal Title IV-E funds to provide time-limited, clinically appropriate use of congregate care, including Qualified Residential Treatment Programs (QRTPs), for youth in foster care. October 1, 2021 marked the deadline for states to begin implementing these FFPSA congregate care reforms. From June to September 2022, we conducted a mixed-methods study to obtain a baseline understanding of implementation barriers, successes, and recommendations to inform congregate care policy and practice. METHODS: We fielded a national survey with state child welfare agency directors and conducted focus groups with youth with QRTP experiences, child welfare agency administrators, and QRTP executive leaders. We integrated a descriptive analysis of survey data with focus group themes to summarize state implementation progress. RESULTS: A total of 47 states (90%) responded to the survey. Most states reported ongoing congregate care reforms aligned with FFPSA, reducing the use of congregate care and increasing kinship foster care. QRTPs have become the primary congregate care setting. Top implementation barriers concerned workforce resource and capacity constraints, funding, and access to therapeutic foster care models and foster families. Focus group themes converged on the lack of tailored treatment, quality staff, coordinated aftercare, and a need for QRTP outcome evidence. CONCLUSIONS: Early implementation lessons of FFPSA congregate care reforms call for additional funding and technical assistance, oversight of congregate care, professionalization and investment in QRTP staff, youth advisory boards to promote youth-driven treatment, and performance- and outcome-based monitoring of QRTPs.
- 27 June 2024
- Published by American Academy of Pediatrics (AAP) in Pediatrics
- Vol. 154 (1)
State Implementation of Congregate Care Reforms for Children in Foster Care
OBJECTIVES: The Family First Prevention Services Act (FFPSA) allows states to use federal Title IV-E funds to provide time-limited, clinically appropriate use of congregate care, including Qualified Residential Treatment Programs (QRTPs), for youth in foster care. October 1, 2021 marked the deadline for states to begin implementing these FFPSA congregate care reforms. From June to September 2022, we conducted a mixed-methods study to obtain a baseline understanding of implementation barriers, successes, and recommendations to inform congregate care policy and practice. METHODS: We fielded a national survey with state child welfare agency directors and conducted focus groups with youth with QRTP experiences, child welfare agency administrators, and QRTP executive leaders. We integrated a descriptive analysis of survey data with focus group themes to summarize state implementation progress. RESULTS: A total of 47 states (90%) responded to the survey. Most states reported ongoing congregate care reforms aligned with FFPSA, reducing the use of congregate care and increasing kinship foster care. QRTPs have become the primary congregate care setting. Top implementation barriers concerned workforce resource and capacity constraints, funding, and access to therapeutic foster care models and foster families. Focus group themes converged on the lack of tailored treatment, quality staff, coordinated aftercare, and a need for QRTP outcome evidence. CONCLUSIONS: Early implementation lessons of FFPSA congregate care reforms call for additional funding and technical assistance, oversight of congregate care, professionalization and investment in QRTP staff, youth advisory boards to promote youth-driven treatment, and performance- and outcome-based monitoring of QRTPs.
- 17 May 2023
- Published by SAGE Publications in Journal of Child and Adolescent Psychopharmacology
- Vol. 33 (4) , 149-155
Psychotropic Medication Prescribing: Youth in Foster Care Compared with Other Medicaid Enrollees
Objective: To compare the prevalence of psychotropic medication dispensing among youth in foster care with those among nonfoster youth on Medicaid. Methods: Children ages 1–18 years in a region of a large southern state who were enrolled in their respective Medicaid plan for at least 30 days between 2014 and 2016 and had at least one health care claim were included. Medicaid prescription claims were categorized by class: alpha agonists, anxiolytics, antidepressants, antipsychotics, mood stabilizers, and stimulants. Primary mental health (MH) or developmental disorder (DD) diagnostic groups were identified for each class. Analyses included chi-square tests, t -tests, Wilcoxon sign rank tests, and logistic regression. Results: A total of 388,914 nonfoster and 8426 children in foster care were included. Overall, 8% of nonfoster and 35% of foster youth were dispensed at least one prescription for a psychotropic medication. Prevalence was higher for youth in care within each drug class and, with one exception, across all age groups. Among children dispensed a psychotropic medication, the mean number of drug classes dispensed was 1.4 (SD 0.8) and 2.9 (SD 1.4) for nonfoster and foster youth, respectively ( p < 0.000). Except for anxiolytics and mood stabilizers, more children in foster care were dispensed psychotropic medications without an MH or DD diagnosis. Finally, children in foster care experienced 6.8 (95% CI: 6.5–7.2) times higher odds of being dispensed a psychotropic medication than their nonfoster peers, after controlling for age group, gender, and number of mental and developmental diagnoses. Conclusions: Across all age groups, children in foster care on Medicaid were dispensed psychotropic medications disproportionately more than their nonfoster peers on Medicaid. In addition, children in foster care were significantly more likely to dispense psychotropic medication absent an MH or DD diagnosis.
- 17 May 2023
- Published by SAGE Publications in Journal of Child and Adolescent Psychopharmacology
- Vol. 33 (4) , 149-155
Psychotropic Medication Prescribing: Youth in Foster Care Compared with Other Medicaid Enrollees
Objective: To compare the prevalence of psychotropic medication dispensing among youth in foster care with those among nonfoster youth on Medicaid. Methods: Children ages 1–18 years in a region of a large southern state who were enrolled in their respective Medicaid plan for at least 30 days between 2014 and 2016 and had at least one health care claim were included. Medicaid prescription claims were categorized by class: alpha agonists, anxiolytics, antidepressants, antipsychotics, mood stabilizers, and stimulants. Primary mental health (MH) or developmental disorder (DD) diagnostic groups were identified for each class. Analyses included chi-square tests, t -tests, Wilcoxon sign rank tests, and logistic regression. Results: A total of 388,914 nonfoster and 8426 children in foster care were included. Overall, 8% of nonfoster and 35% of foster youth were dispensed at least one prescription for a psychotropic medication. Prevalence was higher for youth in care within each drug class and, with one exception, across all age groups. Among children dispensed a psychotropic medication, the mean number of drug classes dispensed was 1.4 (SD 0.8) and 2.9 (SD 1.4) for nonfoster and foster youth, respectively ( p < 0.000). Except for anxiolytics and mood stabilizers, more children in foster care were dispensed psychotropic medications without an MH or DD diagnosis. Finally, children in foster care experienced 6.8 (95% CI: 6.5–7.2) times higher odds of being dispensed a psychotropic medication than their nonfoster peers, after controlling for age group, gender, and number of mental and developmental diagnoses. Conclusions: Across all age groups, children in foster care on Medicaid were dispensed psychotropic medications disproportionately more than their nonfoster peers on Medicaid. In addition, children in foster care were significantly more likely to dispense psychotropic medication absent an MH or DD diagnosis.
- 21 October 2021
- Published by Wolters Kluwer Health in Journal of Developmental & Behavioral Pediatrics
- Vol. 43 (5) , e296-e303
Mental Health and Developmental Disorder Diagnoses of Foster and Nonfoster Children Enrolled in Medicaid
Objective: This study used Medicaid claims to compare the prevalence of mental health disorders (MHDs) and developmental disorders (DDs) between foster and nonfoster youth. Methods: Medicaid claims data were used to identify MHDs and DDs. Diagnosis codes were categorized into 16 MHD and 8 DD groups. Children were enrolled in their respective Medicaid plan for at least 30 days and had at least 1 health care encounter generating a claim. Prevalence was compared between children in foster care and children not in foster care overall and by age group. Logistic regression was used to compare the odds of having an MHD or DD diagnosis. Results: Of the 8706 children in foster care, 20.1% had an MHD compared with 9.7% of the 392,815 nonfoster children. Overall, the 5 most prevalent MHD and DD conditions among foster youth were attention-deficit/hyperactivity disorder (ADHD) (11.0%), miscellaneous (9.3%), bipolar disorders (5.6%), communication disorders (5.4%), and depressive disorders (5.1%). The 5 most prevalent conditions among children not in foster care were ADHD (6.1%); communication disorders (3.0%); disruptive, impulse control, and conduct disorders (2.7%); specific learning disorders (2.5%); and trauma and stressor-related disorders (2.4%). Anxiety was significantly higher among nonfoster children. The prevalence of the most common conditions by age group is reported. Overall, children in foster care had 2.5 and 2.3 times higher odds of having an MHD or DD diagnosis, respectively. Conclusion: Children in foster care had significantly higher rates of mental health and DD diagnoses compared with children not in foster care.
- 21 October 2021
- Published by Wolters Kluwer Health in Journal of Developmental & Behavioral Pediatrics
- Vol. 43 (5) , e296-e303
Mental Health and Developmental Disorder Diagnoses of Foster and Nonfoster Children Enrolled in Medicaid
Objective: This study used Medicaid claims to compare the prevalence of mental health disorders (MHDs) and developmental disorders (DDs) between foster and nonfoster youth. Methods: Medicaid claims data were used to identify MHDs and DDs. Diagnosis codes were categorized into 16 MHD and 8 DD groups. Children were enrolled in their respective Medicaid plan for at least 30 days and had at least 1 health care encounter generating a claim. Prevalence was compared between children in foster care and children not in foster care overall and by age group. Logistic regression was used to compare the odds of having an MHD or DD diagnosis. Results: Of the 8706 children in foster care, 20.1% had an MHD compared with 9.7% of the 392,815 nonfoster children. Overall, the 5 most prevalent MHD and DD conditions among foster youth were attention-deficit/hyperactivity disorder (ADHD) (11.0%), miscellaneous (9.3%), bipolar disorders (5.6%), communication disorders (5.4%), and depressive disorders (5.1%). The 5 most prevalent conditions among children not in foster care were ADHD (6.1%); communication disorders (3.0%); disruptive, impulse control, and conduct disorders (2.7%); specific learning disorders (2.5%); and trauma and stressor-related disorders (2.4%). Anxiety was significantly higher among nonfoster children. The prevalence of the most common conditions by age group is reported. Overall, children in foster care had 2.5 and 2.3 times higher odds of having an MHD or DD diagnosis, respectively. Conclusion: Children in foster care had significantly higher rates of mental health and DD diagnoses compared with children not in foster care.
- 24 February 2021
- Published by American Academy of Pediatrics (AAP)
- Vol. 147 (3 MeetingA) , 83-84
A Comparison Study of Mental Health Diagnoses of Foster and Non-Foster Children on Medicaid
- 24 February 2021
- Published by American Academy of Pediatrics (AAP)
- Vol. 147 (3 MeetingA) , 83-84
A Comparison Study of Mental Health Diagnoses of Foster and Non-Foster Children on Medicaid
- Open Access
- 18 December 2020
- Published by Texas Medical Center Library in Journal of Applied Research on Children: Informing Policy for Children at Risk
- Vol. 11 (2) , 6
Community Readiness to Align and Better Support Families with Perinatal Substance Use Issues and the Impacts of the Covid-19 Pandemic on Progress
Problem: Drug overdose is the leading cause of maternal death in Texas. More than 60% of children in custody of Texas Child Protective Services (CPS) have substance use listed as a contributing factor in their CPS case, compared to the national rate of 34%. Pregnant and postpartum women and infants are a special population impacted by substance use and require a coordinated response from multiple sectors to ensure optimal outcomes for both the mother and her infant. Purpose: In 2018, needs and readiness assessments were conducted in Houston, Texas, focused on improving care and service coordination for pregnant women with substance use disorder (SUD). The purpose of this paper is to briefly describe the results of the assessments and discuss how the Covid-19 pandemic has impacted implementation of the recommendations. Methods: In late 2018, 59 stakeholders from 5 different sectors were interviewed to assess the current system of care and identify recommendations they felt would improve outcomes for pregnant women with SUD. These interviews were followed by 5 collaborative meetings with stakeholders to finalize the recommendations, and a readiness assessment (n=25) to determine the feasibility of implementing the recommendations. The goals of this survey were to determine which of these recommendations were most important, had organizational support for implementation, and would result in improvements within a year of being implemented. Interviews were conducted again in 2020 (n=9) to describe the progress that had been made on the recommendations and assess the impact the Covid-19 pandemic has had on implementing programs and initiatives that support peripartum women with SUDs. Results/Discussion: The stakeholder interviews revealed substantial cross-sector misunderstanding about each sector’s roles and responsibilities. Further, several barriers to coordination were identified. Interviews and collaborative meetings led to the development of 25 recommendations that would improve cross-sector collaboration. There were 25 completed responses to the readiness survey focused on implementing these recommendations. Of the recommendations, 9 had above-average ratings on importance and had ratings indicating substantial short-term impact for pregnant women. Six additional recommendations had above-average ratings on importance, but it was determined that their benefits take longer to be seen. Progress made towards 8 of the recommendations and how the Covid-19 pandemic has impacted this progress are described. Implications: The Covid-19 pandemic has created both opportunities and barriers to progress in the treatment and care of pregnant women with SUD. This analysis identifies resulting changes that must be considered for future planning and intervention implementation.
- 18 December 2020
- Published by Texas Medical Center Library in Journal of Applied Research on Children: Informing Policy for Children at Risk
- Vol. 11 (2) , 6
Open AccessCommunity Readiness to Align and Better Support Families with Perinatal Substance Use Issues and the Impacts of the Covid-19 Pandemic on Progress
Problem: Drug overdose is the leading cause of maternal death in Texas. More than 60% of children in custody of Texas Child Protective Services (CPS) have substance use listed as a contributing factor in their CPS case, compared to the national rate of 34%. Pregnant and postpartum women and infants are a special population impacted by substance use and require a coordinated response from multiple sectors to ensure optimal outcomes for both the mother and her infant. Purpose: In 2018, needs and readiness assessments were conducted in Houston, Texas, focused on improving care and service coordination for pregnant women with substance use disorder (SUD). The purpose of this paper is to briefly describe the results of the assessments and discuss how the Covid-19 pandemic has impacted implementation of the recommendations. Methods: In late 2018, 59 stakeholders from 5 different sectors were interviewed to assess the current system of care and identify recommendations they felt would improve outcomes for pregnant women with SUD. These interviews were followed by 5 collaborative meetings with stakeholders to finalize the recommendations, and a readiness assessment (n=25) to determine the feasibility of implementing the recommendations. The goals of this survey were to determine which of these recommendations were most important, had organizational support for implementation, and would result in improvements within a year of being implemented. Interviews were conducted again in 2020 (n=9) to describe the progress that had been made on the recommendations and assess the impact the Covid-19 pandemic has had on implementing programs and initiatives that support peripartum women with SUDs. Results/Discussion: The stakeholder interviews revealed substantial cross-sector misunderstanding about each sector’s roles and responsibilities. Further, several barriers to coordination were identified. Interviews and collaborative meetings led to the development of 25 recommendations that would improve cross-sector collaboration. There were 25 completed responses to the readiness survey focused on implementing these recommendations. Of the recommendations, 9 had above-average ratings on importance and had ratings indicating substantial short-term impact for pregnant women. Six additional recommendations had above-average ratings on importance, but it was determined that their benefits take longer to be seen. Progress made towards 8 of the recommendations and how the Covid-19 pandemic has impacted this progress are described. Implications: The Covid-19 pandemic has created both opportunities and barriers to progress in the treatment and care of pregnant women with SUD. This analysis identifies resulting changes that must be considered for future planning and intervention implementation.